NSRX
NSRX
AMEX · Pharmaceuticals

Nasus Pharma Ltd

$2.60
+0.11 (+4.42%)
As of Mar 25, 4:51 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +1,601.2% upside
Low Target $32.29
Average Target $44.23
High Target $55.91
Current Price $2.60
Current
$2.60
Target
$44.23
$32.29 $44.23 avg $55.91
Scenario Analysis
Bear Case
$32.29
1,141.9%
Low target
Base Case
$44.23
+1,601.2%
Avg target
Bull Case
$55.91
+2,050.4%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$9.99
-74.0% from high
52-Week Low
$2.40
+8.3% from low
Target vs 52W High
$44.23
+342.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%